ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - Insider Trades

Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.43 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ARTL stock inside the company?

Recent ARTL insider activity includes Gorgas Gregory D. bought 1.20K and Gorgas Gregory D. bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ARTL Key Metrics

Key financial metrics for ARTL
MetricValue
Price$1.43
Market Cap$3.19M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$85.80
52-Week Low$1.25
Volume9.98K
Avg Volume0
Revenue (TTM)$0
Net Income$-9.83M
Gross Margin0.00%

Recent ARTL Insider Trades

  • Gorgas Gregory D. bought 1.20K (~$4.80K) on Aug 12, 2022.
  • Gorgas Gregory D. bought 1.20K (~$4.84K) on Aug 11, 2022.

Latest ARTL News

ARTL Analyst Consensus

ARTL analyst coverage data. Average price target: $0.00.

Common questions about ARTL

Who is trading ARTL stock inside the company?
Recent ARTL insider activity includes Gorgas Gregory D. bought 1.20K and Gorgas Gregory D. bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ARTL?
Yes. Rallies tracks ARTL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ARTL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.
ARTL

ARTL